ST
Spero Therapeutics Inc
🇺🇸XNAS.SPROUnited StatesHealthcare
$1.11USDdown -0.01 (-0.89%)ClosedDelayed7:41 AM
Price$1.11-0.01 (-0.89%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US84833T1034
- CUSIP
- 84833T103
Company
- Employees
- 25
- Headquarters
- Cambridge, United States
- CEO
- Ms. Esther P. Rajavelu
Market
- Shares outstanding
- 58.2M
- Market cap
- $64.64M
Highlights
- Market cap
- $64.64M
- EPS LTM
- $0.13calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- 8.76calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $42.96M-6.98%down year on year
- Net income
- $7.38M+113.77%up year on year
- Gross margin
- 100%+174.43%up year on year
- Free cash flow
- $19.58M+160.56%up year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.